A detailed history of Stifel Financial Corp transactions in Inari Medical, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 13,594 shares of NARI stock, worth $676,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,594
Previous 12,917 5.24%
Holding current value
$676,981
Previous $838,000 22.2%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$40.65 - $65.76 $27,520 - $44,519
677 Added 5.24%
13,594 $652,000
Q4 2023

Feb 12, 2024

BUY
$48.3 - $68.06 $36,273 - $51,113
751 Added 6.17%
12,917 $838,000
Q3 2023

Nov 13, 2023

BUY
$54.2 - $71.67 $225,201 - $297,788
4,155 Added 51.87%
12,166 $795,000
Q2 2023

Aug 14, 2023

BUY
$56.23 - $71.17 $63,090 - $79,852
1,122 Added 16.29%
8,011 $465,000
Q1 2023

May 12, 2023

SELL
$53.43 - $68.12 $14,693 - $18,733
-275 Reduced 3.84%
6,889 $425,000
Q4 2022

Feb 13, 2023

SELL
$61.23 - $83.62 $129,868 - $177,358
-2,121 Reduced 22.84%
7,164 $455,000
Q3 2022

Nov 14, 2022

SELL
$65.58 - $84.69 $48,857 - $63,094
-745 Reduced 7.43%
9,285 $674,000
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $33,884 - $60,976
650 Added 6.93%
10,030 $682,000
Q1 2022

May 13, 2022

BUY
$64.92 - $99.47 $5,128 - $7,858
79 Added 0.85%
9,380 $850,000
Q4 2021

Feb 14, 2022

BUY
$76.51 - $93.96 $75,285 - $92,456
984 Added 11.83%
9,301 $849,000
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $2,281 - $3,071
32 Added 0.39%
8,317 $674,000
Q2 2021

Aug 13, 2021

SELL
$79.62 - $114.85 $11,704 - $16,882
-147 Reduced 1.74%
8,285 $772,000
Q1 2021

May 14, 2021

BUY
$77.91 - $125.92 $12,076 - $19,517
155 Added 1.87%
8,432 $903,000
Q4 2020

Feb 12, 2021

BUY
$60.0 - $87.29 $496,620 - $722,499
8,277 New
8,277 $722,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.66B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.